Sherry R. Crowe, Ph.D.
Affiliations: | 2001 | Medical University of South Carolina, Charleston, SC, United States |
Area:
ImmunologyGoogle:
"Sherry Crowe"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Steven D. London | grad student | 2001 | MUSC | |
| (Reovirus 1 /L as a model to study the induction of optimal immunity at mucosal and systemic sites.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Slight-Webb SR, Bagavant H, Crowe SR, et al. (2015) Influenza A (H1N1) virus infection triggers severe pulmonary inflammation in lupus-prone mice following viral clearance. Journal of Autoimmunity. 57: 66-76 |
| Smith K, Crowe SR, Garman L, et al. (2012) Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization. Vaccine. 30: 4276-83 |
| Crowe SR, Merrill JT, Vista ES, et al. (2011) Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features. Arthritis and Rheumatism. 63: 2396-406 |
| Crowe SR, Garman L, Engler RJ, et al. (2011) Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity. Vaccine. 29: 3670-8 |
| Crowe SR, Ash LL, Engler RJ, et al. (2010) Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge. The Journal of Infectious Diseases. 202: 251-60 |
| Nguyen ML, Crowe SR, Kurella S, et al. (2009) Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies. Infection and Immunity. 77: 162-9 |
| Crowe SR, Miller SC, Woodland DL. (2006) Identification of protective and non-protective T cell epitopes in influenza. Vaccine. 24: 452-6 |
| Crowe SR, Miller SC, Brown DM, et al. (2006) Uneven distribution of MHC class II epitopes within the influenza virus. Vaccine. 24: 457-67 |
| Crowe SR, Miller SC, Shenyo RM, et al. (2005) Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge. Journal of Immunology (Baltimore, Md. : 1950). 174: 696-701 |
| Crowe SR, Turner SJ, Miller SC, et al. (2003) Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections. The Journal of Experimental Medicine. 198: 399-410 |